Detalhe da pesquisa
1.
Evidence-based impact projections of single-dose human papillomavirus vaccination in India: a modelling study.
Lancet Oncol
; 23(11): 1419-1429, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36174583
2.
Summary statement on screening for prostate cancer in Europe.
Int J Cancer
; 142(4): 741-746, 2018 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29023685
3.
Comparative effectiveness of prostate cancer screening between the ages of 55 and 69 years followed by active surveillance.
Cancer
; 124(3): 507-513, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29231973
4.
The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trials.
Cancer
; 124(6): 1197-1206, 2018 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29211316
5.
Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.
Ann Intern Med
; 167(7): 449-455, 2017 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28869989
6.
When should active surveillance for prostate cancer stop if no progression is detected?
Prostate
; 77(9): 962-969, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28419541
7.
Is prostate cancer different in black men? Answers from 3 natural history models.
Cancer
; 123(12): 2312-2319, 2017 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28436011
8.
Estimating the risks and benefits of active surveillance protocols for prostate cancer: a microsimulation study.
BJU Int
; 119(4): 560-566, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27222299
9.
Estimating the individual benefit of immediate treatment or active surveillance for prostate cancer after screen-detection in older (65+) men.
Int J Cancer
; 138(10): 2522-8, 2016 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26695380
10.
Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysis.
Cancer
; 122(21): 3386-3393, 2016 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27459245
11.
Screening for prostate cancer in the US? Reduce the harms and keep the benefit.
Int J Cancer
; 136(7): 1600-7, 2015 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25123412
12.
Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits.
Ann Intern Med
; 161(2): 104-12, 2014 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25023249
13.
Choosing a Metamodel of a Simulation Model for Uncertainty Quantification.
Med Decis Making
; 42(1): 28-42, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34098793
14.
Evaluating Parameter Uncertainty in a Simulation Model of Cancer Using Emulators.
Med Decis Making
; 39(4): 405-413, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31179833